# US 2015/0105439 A1 · Treatment of drug-resistant cancer with 2-aryl-2-(3-indolyl) acetohydroxamates

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0105439 A1
- Document ID: US20150105439A1
- Status: Published application
- Kind: A1
- Application number: 14/516,543
- Filed: 2014-10-16
- Published: 2015-04-16
- Earliest claimed: 2013-10-16
- Assignees: New Mexico Technical Research Foundation
- Applicants: New Mexico Technical Research Foundation
- Inventors: Alexander V. Akensov; Snezna Rogelj; Liliya Frolova; Alexander Kornienko; Gabriel Avilucea
- Web page: https://patentgrep.com/patent/US20150105439A1

## CPC

- C07D 209/20: substituted additionally by nitrogen atoms, e.g. tryptophane
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

A pharmaceutical composition, a method of producing same, and a method of providing cancer therapy therein comprising a pharmaceutically acceptable excipient or carrier and a compound Formula 3 as follows: or a pharmaceutically acceptable salt or prodrug thereof, wherein: R1, R2, R3 and R4 are optionally substituted and are hydrogen, haloalkyl, aryl, fused aryl, carbocyclic, a heterocyclic group, a heteroaryl group, C1-10 alkyl, alkenyl, alkynyl, arylalkyl, arylalkenyl, arylalkynyl, heteroarylalkyl, heteroarylalkenyl, carbocycloalkyl, heterocycloalkyl, hydroxyalkyl, aminoalkyl, carboxyalkyl, nitroalkyl, cyanoalkyl, acetamidoalkyl, acyloxyalkyl, hydroxyl, alkoxy, acetoxy, amino, alkylamino, acetamido.

## Claims

### Claim 1

A pharmaceutical composition comprising a pharmaceutically acceptable excipient or carrier and a compound of Formula 3 as follows:
or a pharmaceutically acceptable salt or prodrug thereof, wherein:
R1, R2, R3 and R4 are optionally substituted and are hydrogen, haloalkyl, aryl, fused aryl, carbocyclic, a heterocyclic group, a heteroaryl group, C1-10 alkyl, alkenyl, alkynyl, arylalkyl, arylalkenyl, arylalkynyl, heteroarylalkyl, heteroarylalkenyl, carbocycloalkyl, heterocycloalkyl, hydroxyalkyl, aminoalkyl, carboxyalkyl, nitroalkyl, cyanoalkyl, acetamidoalkyl, acyloxyalkyl, hydroxyl, alkoxy, acetoxy, amino, alkylamino, acetamido.

### Claim 2 (depends on 1)

A method of treating cancer, especially drug-resistant tumors, comprising administering an effective amount of one or more compounds of Formula 3 of claim 1.

### Claim 3 (depends on 1)

A method of producing the compounds of Formula 3 of claim 1.
